BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 32598755)

  • 1. [Glucocorticosteroids for people with alcoholic hepatitis (Cochrane review)].
    Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
    Ter Arkh; 2019 Aug; 91(8):52-66. PubMed ID: 32598755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticosteroids for people with alcoholic hepatitis.
    Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD001511. PubMed ID: 29096421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticosteroids for people with alcoholic hepatitis.
    Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001511. PubMed ID: 30964545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.
    Fairfield C; Penninga L; Powell J; Harrison EM; Wigmore SJ
    Cochrane Database Syst Rev; 2015 Dec; (12):CD007606. PubMed ID: 26666504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline for alcoholic hepatitis.
    Whitfield K; Rambaldi A; Wetterslev J; Gluud C
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD007339. PubMed ID: 19821406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha inhibitors for ankylosing spondylitis.
    Maxwell LJ; Zochling J; Boonen A; Singh JA; Veras MM; Tanjong Ghogomu E; Benkhalti Jandu M; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2015 Apr; (4):CD005468. PubMed ID: 25887212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wound infiltration with local anaesthetic agents for laparoscopic cholecystectomy.
    Loizides S; Gurusamy KS; Nagendran M; Rossi M; Guerrini GP; Davidson BR
    Cochrane Database Syst Rev; 2014 Mar; (3):CD007049. PubMed ID: 24619479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review: glucocorticosteroids for alcoholic hepatitis--a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials.
    Rambaldi A; Saconato HH; Christensen E; Thorlund K; Wetterslev J; Gluud C
    Aliment Pharmacol Ther; 2008 Jun; 27(12):1167-78. PubMed ID: 18363896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
    Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D supplementation for prevention of cancer in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Krstic G; Wetterslev J; Gluud C
    Cochrane Database Syst Rev; 2014 Jun; (6):CD007469. PubMed ID: 24953955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2015 Sep; (9):CD001939. PubMed ID: 26377410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticosteroids for viral hepatitis C.
    Brok J; Mellerup MT; Krogsgaard K; Gluud C
    Cochrane Database Syst Rev; 2004; 2004(2):CD002904. PubMed ID: 15106184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis.
    Vergis N; Patel V; Bogdanowicz K; Czyzewska-Khan J; Fiorentino F; Day E; Cross M; Foster N; Lord E; Goldin R; Forrest E; Thursz M
    Trials; 2021 Nov; 22(1):792. PubMed ID: 34763711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis.
    Parker R; Armstrong MJ; Corbett C; Rowe IA; Houlihan DD
    Aliment Pharmacol Ther; 2013 May; 37(9):845-54. PubMed ID: 23489011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticosteroids for sepsis in children. A protocol for a systematic review.
    Korang SK; Gluud C; Jakobsen JC
    Acta Anaesthesiol Scand; 2019 Jul; 63(6):819-826. PubMed ID: 30919946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter to the Editor: Glucocorticosteroids for Alcohol-Associated Hepatitis.
    Varganova DL; Pavlov CS; Casazza G; Nikolova D; Gluud C
    Hepatology; 2020 Apr; 71(4):1524. PubMed ID: 31660631
    [No Abstract]   [Full Text] [Related]  

  • 19. Past, Present, and Future Therapies for Alcohol-associated Hepatitis.
    Condon S; Jophlin LL
    Clin Ther; 2023 Dec; 45(12):1171-1176. PubMed ID: 37980219
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.